Northwest & Ethical Investments’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12M | Sell |
23,999
-3,768
| -14% | -$1.81M | 0.28% | 94 |
|
|
2026
Q1 | $13.6M | Buy |
27,767
+255
| +0.9% | +$138K | 0.32% | 90 |
|
|
2025
Q4 | $15.9M | Sell |
27,512
-720
| -3% | -$407K | 0.36% | 82 |
|
|
2025
Q3 | $13.6M | Buy |
28,232
+5,617
| +25% | +$2.61M | 0.32% | 96 |
|
|
2025
Q2 | $9.17M | Sell |
22,615
-5,143
| -19% | -$2.15M | 0.23% | 125 |
|
|
2025
Q1 | $13.8M | Buy |
27,758
+8,542
| +44% | +$4.63M | 0.37% | 87 |
|
|
2024
Q4 | $10M | Sell |
19,216
-1,876
| -9% | -$1.03M | 0.27% | 118 |
|
|
2024
Q3 | $13M | Buy |
21,092
+6,672
| +46% | +$3.95M | 0.34% | 99 |
|
|
2024
Q2 | $7.97M | Sell |
14,420
-40
| -0.3% | -$22.9K | 0.23% | 128 |
|
|
2024
Q1 | $8.4M | Buy |
14,460
+2,671
| +23% | +$1.5M | 0.24% | 131 |
|
|
2023
Q4 | $6.26M | Hold |
11,789
| – | – | 0.19% | 149 |
|
|
2023
Q3 | $5.97M | Hold |
11,789
| – | – | 0.2% | 148 |
|
|
2023
Q2 | $6.15M | Sell |
11,789
-670
| -5% | -$362K | 0.2% | 150 |
|
|
2023
Q1 | $7.18M | Buy |
12,459
+562
| +5% | +$317K | 0.24% | 132 |
|
|
2022
Q4 | $6.55M | Sell |
11,897
-3,889
| -25% | -$2.06M | 0.23% | 141 |
|
|
2022
Q3 | $8.01M | Sell |
15,786
-8,692
| -36% | -$4.86M | 0.32% | 100 |
|
|
2022
Q2 | $13.3M | Sell |
24,478
-15,544
| -39% | -$8.56M | 0.5% | 65 |
|
|
2022
Q1 | $23.6M | Sell |
40,022
-7,140
| -15% | -$4.1M | 0.76% | 34 |
|
|
2021
Q4 | $31.5M | Sell |
47,162
-4,134
| -8% | -$2.58M | 0.93% | 27 |
|
|
2021
Q3 | $29.3M | Buy |
51,296
+5,227
| +11% | +$2.87M | 0.95% | 24 |
|
|
2021
Q2 | $23.2M | Sell |
46,069
-1,966
| -4% | -$928K | 0.75% | 37 |
|
|
2021
Q1 | $21.9M | Buy |
48,035
+1,705
| +4% | +$814K | 0.77% | 33 |
|
|
2020
Q4 | $21.6M | Buy |
46,330
+2,213
| +5% | +$1.04M | 0.83% | 29 |
|
|
2020
Q3 | $19.5M | Sell |
44,117
-4,122
| -9% | -$1.7M | 0.86% | 24 |
|
|
2020
Q2 | $17.5M | Buy |
48,239
+13,068
| +37% | +$4.38M | 0.83% | 24 |
|
|
2020
Q1 | $9.97M | Sell |
35,171
-4,541
| -11% | -$1.43M | 0.58% | 42 |
|
|
2019
Q4 | $12.9M | Buy |
39,712
+235
| +0.6% | +$71.3K | 0.58% | 39 |
|
|
2019
Q3 | $11.5M | Buy |
39,477
+6,873
| +21% | +$1.97M | 0.56% | 42 |
|
|
2019
Q2 | $9.58M | Sell |
32,604
-779
| -2% | -$215K | 0.48% | 54 |
|
|
2019
Q1 | $9.14M | Buy |
33,383
+146
| +0.4% | +$36.3K | 0.48% | 53 |
|
|
2018
Q4 | $7.44M | Buy |
33,237
+11,518
| +53% | +$2.7M | 0.44% | 55 |
|
|
2018
Q3 | $5.3M | Sell |
21,719
-1,251
| -5% | -$288K | 0.33% | 92 |
|
|
2018
Q2 | $4.76M | Sell |
22,970
-6,066
| -21% | -$1.29M | 0.32% | 93 |
|
|
2018
Q1 | $5.99M | Buy |
29,036
+2,601
| +10% | +$546K | 0.4% | 65 |
|
|
2017
Q4 | $5.02M | Buy |
26,435
+5,666
| +27% | +$1.09M | 0.33% | 85 |
|
|
2017
Q3 | $3.93M | Sell |
20,769
-13,849
| -40% | -$2.51M | 0.24% | 109 |
|
|
2017
Q2 | $6.04M | Buy |
34,618
+5,600
| +19% | +$941K | 0.41% | 54 |
|
|
2017
Q1 | $4.52M | Buy |
29,018
+5,248
| +22% | +$802K | 0.31% | 86 |
|
|
2016
Q4 | $3.35M | Buy |
23,770
+1,058
| +5% | +$156K | 0.23% | 111 |
|
|
2016
Q3 | $3.61M | Sell |
22,712
-10,910
| -32% | -$1.68M | 0.25% | 97 |
|
|
2016
Q2 | $4.97M | Sell |
33,622
-32,850
| -49% | -$4.85M | 0.38% | 66 |
|
|
2016
Q1 | $9.41M | Buy |
66,472
+17,122
| +35% | +$2.29M | 0.63% | 48 |
|
|
2015
Q4 | $7M | Buy |
+49,350
| New | +$6.58M | 0.51% | 63 |
|
Other funds holding TMO
Northwest & Ethical Investments's TMO Position: Q2 2026 in Review
Northwest & Ethical Investments reduced its Thermo Fisher Scientific (TMO) stake by 14% in Q2 2026, selling an estimated $1.81M and leaving 23,999 shares worth $12M. The position accounts for 0.28% of the portfolio, ranked #94.
Northwest & Ethical Investments first reported a position in TMO in Q4 2015 and has held it in 43 quarters since. The position peaked at $31.5M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Northwest & Ethical Investments held 23,999 shares of Thermo Fisher Scientific worth $12M as of Q2 2026.
- Northwest & Ethical Investments sold 3,768 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.81M.
- Thermo Fisher Scientific made up 0.28% of Northwest & Ethical Investments's portfolio in Q2 2026, its #94 holding.
- Northwest & Ethical Investments first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 43 quarters since.
- Northwest & Ethical Investments's Thermo Fisher Scientific position peaked at $31.5M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.